Synonyms for vhh or Related words with vhh
Examples of "vhh"
Caplacizumab (INN) is a bivalent
designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis.
At the same time the "Verkehrsbetriebe Hamburg-Holstein (
)" received 20 hybrid buses from Volvo and two fully electric buses from Italian manufacturer Rampini.
HVV was founded on November 29, 1965, with the four initial partners the Hamburger Hochbahn AG, the Deutsche Bundesbahn, the HADAG Seetouristik und Fährdienst AG and Verkehrsbetriebe Hamburg-Holstein (
). The first results that the new organization delivered came on January 1, 1967, with a unified fare structure, pooling of receipts and coordinated systemwide timetables across all modes of transport.
The Hamburger Verkehrsverbund was founded on 29 November 1965 with the four initial partners the Hamburger Hochbahn AG, the Deutsche Bundesbahn, the HADAG Seetouristik und Fährdienst AG and Verkehrsbetriebe Hamburg-Holstein (
). On 30 September 1978, after 84 years of service, the last tram served line no. 2 from "Rathausmarkt" to "Schnelsen".
HVV acts is the overall coordinating body for transport in the conurbation, with representation by the Hamburger Hochbahn (Hamburg elevated railway); Deutsche Bahn (German Federal Railroads); AKN railway company (Altona—Kaltenkirchen—Neumünster Railway); HADAG Seetouristik und Fährdienst A. G. (HADAG sea-tourism and ferry service plc);
(Verkehrsbetriebe Hamburg-Holstein A.G./ Transporting enterprises Hamburg Holstein Ltd); PVG (Pinneberger Verkehrsgesellschaft, mbH/ Pinneberger public transport company, Ltd); and KVG (Kraftverkehrgesellschaft, GmbH/ Motor Traffic Company, LLC).
Major company for the public bus services is the "Hamburg Hochbahn AG (HHA)" with more than 100 lines and driven per day. Another main operator is the regional and city bus company "Verkehrsbetriebe Hamburg-Holstein (
)", operating many own lines (especially in the outer districts and on outbound lines) and sharing services with the "Hamburger Hochbahn" on several lines. Both companies handed over small parts of their services and some lines to subcontractors and subsidiaries such as "Jasper" or "Süderelbe-Bus."
Armand Dorian was born and raised in Los Angeles, California. He was the valedictorian of his class, graduating "cum laude" in biology with an emphasis in philosophy from UCLA. He has done research and published in human genomics and tropical biology. He received his MD from the John A. Burns School of Medicine, University of Hawaii, which is renowned for its progressive medical curriculum as it integrates alternative and holistic medicine. He continued residency training at the UCLA Emergency Medicine Residency Program. Upon graduation and receipt of his Board Certification, he joined the staff at both UCLA/Westwood and UCLA/Olive View hospitals and became a fellow of the American College of Emergency Physicians. He became the Director of the Emergency Department at Verdugo Hills Hospital and then climbed the hospital hierarchy and was appointed to the position of Chief of Development and Treasurer. Subsequent to the merger between USC and Verdugo Hills Hospital, he became an Associate Professor of Emergency Medicine at USC and was appointed Chairman of the Caduceus Society, USC-
Foundation. Most recently he was appointed Vice Chair of the Emergency Department.
The use of antibodies as the bio-recognition component of biosensors has several drawbacks. They have high molecular weights and limited stability, contain essential disulfide bonds and are expensive to produce. In one approach to overcome these limitations, recombinant binding fragments (Fab, Fv or scFv) or domains (VH,
) of antibodies have been engineered. In another approach, small protein scaffolds with favorable biophysical properties have been engineered to generate artificial families of Antigen Binding Proteins (AgBP), capable of specific binding to different target proteins while retaining the favorable properties of the parent molecule. The elements of the family that specifically bind to a given target antigen, are often selected in vitro by display techniques: phage display, ribosome display, yeast display or mRNA display. The artificial binding proteins are much smaller than antibodies (usually less than 100 amino-acid residues), have a strong stability, lack disulfide bonds and can be expressed in high yield in reducing cellular environments like the bacterial cytoplasm, contrary to antibodies and their derivatives. They are thus especially suitable to create biosensors.
Copyright © 2017